A government investigation or enforcement action can disrupt a business, delay the launch of a new product, or threaten funding. Life sciences companies that participate in federal grant programs need to be aware of the risks associated with non-compliance with rules and regulations governing those programs. On November 20, 2013, Karen Lovitch, David Barmak, Kevin McGinty, and Scott Samuels of Mintz Levin will present a webinar to identify best practices for managing employees and fostering compliance in a growth company environment.
Karen advises industry clients on regulatory, transactional, operational, and enforcement matters. She has deep experience handling FCA investigations and qui tam litigation for laboratories and diagnostics companies.